Blog
About

  • Record: found
  • Abstract: found
  • Article: not found

Global Genomic Diversity of Human Papillomavirus 11 Based on 433 Isolates and 78 Complete Genome Sequences.

1 , 2 , 3 , 3 , 4 , 2 , 5 , 4 , 6 , 7 , 8 , 5 , 9 , 10 , 7 , 11 , 12 , 13 , 10 , 3 , 9 , 3 , 6 , 14 , 3 , 15 , 12 , 16 , 8 , 16 , 15 , 17 , 17 , 18 , 19 , 20 , 21

Journal of virology

American Society for Microbiology

Read this article at

ScienceOpenPublisherPMC
Bookmark
      There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

      Abstract

      Human papillomavirus 11 (HPV11) is an etiological agent of anogenital warts and laryngeal papillomas and is included in the 4-valent and 9-valent prophylactic HPV vaccines. We established the largest collection of globally circulating HPV11 isolates to date and examined the genomic diversity of 433 isolates and 78 complete genomes (CGs) from six continents. The genomic variation within the 2,800-bp E5a-E5b-L1-upstream regulatory region was initially studied in 181/207 (87.4%) HPV11 isolates collected for this study. Of these, the CGs of 30 HPV11 variants containing unique single nucleotide polymorphisms (SNPs), indels (insertions or deletions), or amino acid changes were fully sequenced. A maximum likelihood tree based on the global alignment of 78 HPV11 CGs (30 CGs from our study and 48 CGs from GenBank) revealed two HPV11 lineages (lineages A and B) and four sublineages (sublineages A1, A2, A3, and A4). HPV11 (sub)lineage-specific SNPs within the CG were identified, as well as the 208-bp representative region for CG-based phylogenetic clustering within the partial E2 open reading frame and noncoding region 2. Globally, sublineage A2 was the most prevalent, followed by sublineages A1, A3, and A4 and lineage B.

      Related collections

      Author and article information

      Affiliations
      [1 ] Institute of Pathology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
      [2 ] Department of Microbiology, Faculty of Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong Special Administrative Region, China.
      [3 ] Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
      [4 ] Department of Medical Microbiology and Virology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa.
      [5 ] Human Virology Group, National Council of Scientific and Technical Research, Institute of Molecular and Cell Biology of Rosario, Rosario, Argentina.
      [6 ] Institute of Microbiology, Lausanne University Hospital (CHUV), and University of Lausanne, Lausanne, Switzerland.
      [7 ] Department of Obstetrics and Gynaecology, Cardiff University School of Medicine, Institute of Cancer and Genetics, Cardiff, United Kingdom.
      [8 ] Department of Microbiology and Infectious Diseases, The Royal Women's Hospital, Parkville, Victoria, Australia Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, Victoria, Australia Murdoch Childrens Research Institute, Parkville, Victoria, Australia.
      [9 ] Oncogenic Viruses Service, National Institute of Infectious Diseases-ANLIS Dr. Carlos G. Malbrán, Buenos Aires, Argentina.
      [10 ] Medizinisches Versorgungszentrum wagnerstibbe für Laboratoriumsmedizin und Pathologie GmbH, Hannover, Germany.
      [11 ] Dermatology Research Centre, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong Special Administrative Region, China Department of Health, Social Hygiene Service, Centre for Health Protection, Hong Kong Special Administrative Region, China.
      [12 ] Histocompatibility and Molecular Genetics Laboratory, Dr. Julio C. Perrando Hospital, Resistencia, Chaco, Argentina.
      [13 ] Momate Memorial Laboratory, Tokyo, Japan.
      [14 ] Department of Otorhinolaryngology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa.
      [15 ] Viral Exanthemata and STD Section, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
      [16 ] Department of Experimental Virology, National Reference Laboratory for Papillomaviruses, Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
      [17 ] Department of Otolaryngology, Lithuanian University of Health Sciences, Medical Academy, Kaunas, Lithuania.
      [18 ] DNA Laboratories Sdn. Bhd., UKM-MTDC Technology Centre, Universiti Kebangsaan Malaysia, Bangi, Malaysia.
      [19 ] Department of Molecular Diagnostics, University Hospital for Infectious Diseases Dr. Fran Mihaljević, Zagreb, Croatia.
      [20 ] Departments of Pediatrics, Microbiology and Immunology, Epidemiology and Population Health, Obstetrics and Gynecology, and Women's Health, Albert Einstein College of Medicine, New York, New York, USA.
      [21 ] Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia mario.poljak@mf.uni-lj.si.
      Journal
      J. Virol.
      Journal of virology
      American Society for Microbiology
      1098-5514
      0022-538X
      Jun 01 2016
      : 90
      : 11
      27030261
      JVI.03149-15
      10.1128/JVI.03149-15
      4934746

      Comments

      Comment on this article